$41.22
0.651.6%
At close: Aug 24, 5:00 PM EST
$41.25
0.681.68%
Pre-Market: 7:33 AM EST
Celldex Therapeutics Inc Stock News
CLDXNASDAQ
Latest Celldex Therapeutics Stock News | NASDAQ:CLDX | Benzinga
Get the latest news on Celldex Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Celldex Therapeutics performance
Categories: All
Friday, August 07, 2026
Thursday, August 06, 2026
Wednesday, July 29, 2026
Wednesday, July 22, 2026
- Wells Fargo Maintains Overweight on Celldex T...PRO
- Morgan Stanley Maintains Overweight on Cellde...PRO
- Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- Cantor Fitzgerald Maintains Overweight on Cel...PRO
- Celldex Therapeutics shares are trading lower...PRO
- Celldex Treatment Fails To Relieve Chronic Itch, Abandons Prurigo Nodularis Study
- Canaccord Genuity Maintains Buy on Celldex Th...PRO
